Table 1 Patient-, tumor-, and treatment characteristics
Patient characteristics (n = 86) | N (%) |
|---|---|
Age at time of diagnosis (years) | |
 Median | 57 |
 Q1–Q3 | 41–68 |
Gender | |
 Female | 38 (44) |
 Male | 48 (56) |
Follow-up (months) | |
 Median | 33 |
 Q1–Q3 | 19–61 |
Histology | |
 Undifferentiated pleomorphic high-grade sarcoma | 27 (32) |
 Liposarcoma | 22 (26) |
 Myxofibrosarcoma | 13 (15) |
 Synovial STS | 12 (14) |
 Others | 12 (14) |
Tumor localization | |
 Extremities | 76 (88) |
 Trunk | 10 (12) |
Grading (FNCLCC) | |
 G1 | 6 (7) |
 G2 | 37 (43) |
 G3 | 43 (50) |
T stage | |
 T1 | 18 (21) |
 T2 | 68 (79) |
N stage | |
 N0 | 85 (99) |
 N +  | 1 (1) |
Resection status | |
 R0 | 72 (84) |
 R1 | 8 (9) |
 R2 | 1 (1) |
 Rx | 5 (6) |
Radiation Sequence | |
 Preoperative | 62 (72) |
 Postoperative adjuvant | 19 (22) |
 Postoperative additive | 5 (6) |
RT dose | |
 Preoperative median (Gy); (Q1-Q3) | 50; (50–50) |
 Postoperative/additive median (Gy); (Q1-Q3) | 60; (58–65) |
Chemotherapy | |
 Yes | 2 (2) |
 No | 81 (94) |
 Unknown | 3 (3) |